Journal: Frontiers in Oncology
Article Title: Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
doi: 10.3389/fonc.2019.01015
Figure Lengend Snippet: Association of decreased sPD-L2 serum levels (pg/ml) with the presence of circulating tumor cells (CTC) and the ERCC1+CTC subpopulation. Data about the presence of CTC (A) or ERCC1+CTC (B) was available for 82 and for 57 EOC patients, respectively. Straight line within the violin plot indicates the median. **** p < 0.0001.
Article Snippet: Serum concentrations of sPD-L1 and sPD-L2 were measured by commercial ELISA kits (R&D Systems, GmbH, Wiesbaden-Nordenstadt, Germany) using the manufacturer's protocols with minor modifications.
Techniques: